Secondary prevention of stroke by a primary health care approach: An open-label cluster randomised trial

被引:7
|
作者
Sylaja, P. N. [1 ]
Singh, Gurpreet [2 ]
Sivasambath, S. [1 ]
Arun, K. [1 ]
Jeemon, Panniyammakal [2 ]
Antony, Roni [1 ]
Kalani, Rizwan [3 ]
Gopal, Bipin K. [4 ]
Soman, Biju [2 ]
机构
[1] Sree Chitra Tirunal Inst Med Sci & Technol, Dept Neurol, Comprehens Stroke Care Program, Thiruvananthapuram, Kerala, India
[2] Sree Chitra Tirunal Inst Med Sci & Technol, Achuta Menon Ctr Hlth Sci Studies, Thiruvananthapuram, Kerala, India
[3] Univ Washington, Sch Med, Dept Neurol, Seattle, WA USA
[4] Govt Kerala, Dept Hlth Serv, Thiruvananthapuram, Kerala, India
关键词
Stroke; Secondary prevention; Task shifting; Primary care; Health worker; RISK-FACTORS; DISEASE; EPIDEMIOLOGY; PREVALENCE; COUNTRIES; SERVICES; BURDEN; INDIA;
D O I
10.1016/j.jocn.2020.12.006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and aim: Increasing stroke burden in developing countries necessitates measures to strengthen health systems. We aimed to evaluate whether a Community Health Worker (CHW) based educational intervention will improve risk factor control among stroke survivors and enhance behavior change communication. Method: An open-label, cluster-randomized trial was conducted in rural area of Thiruvananthapuram district, Kerala from December 2017 to December 2018. A CHW-based educational intervention in addition to standard of care was provided in intervention arm and compared to standard clinical care in the control arm with follow-up at three and six months. The primary outcome measures were risk factor control and quality of behavior change communication provided by CHWs. Results: Of the 234 Stroke/TIA survivors enrolled, the mean age (SD) was 59.43 (11.07) years. At 6-month follow up, all patients with smokeless tobacco consumption had quit in the intervention arm (5 at baseline and 0 at six months) and no relapse in smoking was found (as compared to control arm wherein 9 at baseline and one at 6 months). The control of hypertension and diabetes was not significant at 3 months and 6 months in both intervention and control groups. Home visits as well as health education on risk factors by CHWs in the intervention arm were significantly higher. Conclusion: Community health worker-based intervention is feasible in resource constrained settings for secondary stroke prevention. Training of CHW on risk factor control and lifestyle modifications for stroke survivors enhances quality of health education provided by health services. (C) 2020 Elsevier Ltd. All rights reserved.
引用
下载
收藏
页码:53 / 59
页数:7
相关论文
共 50 条
  • [1] SECONDARY PREVENTION IN STROKE BY A PRIMARY HEALTH CARE APPROACH: AN OPEN LABEL CLUSTER RANDOMISED TRIAL
    Singh, G.
    Sambath, S.
    Gopal, B.
    Kalani, R.
    Soman, B.
    INTERNATIONAL JOURNAL OF STROKE, 2020, 15 (1_SUPPL) : 17 - 17
  • [2] Integrating an early childhood development programme into Bangladeshi primary health-care services: an open-label, cluster-randomised controlled trial
    Hamadani, Jena D.
    Mehrin, Syeda F.
    Tofail, Fahmida
    Hasan, Mohammad I.
    Huda, Syed N.
    Baker-Henningham, Helen
    Ridout, Deborah
    Grantham-McGregor, Sally
    LANCET GLOBAL HEALTH, 2019, 7 (03): : E366 - E375
  • [3] Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial
    Lean, Michael E. J.
    Leslie, Wilma S.
    Barnes, Alison C.
    Brosnahan, Naomi
    Thom, George
    McCombie, Louise
    Peters, Carl
    Zhyzhneuskaya, Sviatlana
    Al-Mrabeh, Ahmad
    Hollingsworth, Kieren G.
    Rodrigues, Angela M.
    Rehackova, Lucia
    Adamson, Ashley J.
    Sniehotta, Falko F.
    Mathers, John C.
    Ross, Hazel M.
    McIlvenna, Yvonne
    Stefanetti, Renae
    Trenell, Michael
    Welsh, Paul
    Kean, Sharon
    Ford, Ian
    McConnachie, Alex
    Sattar, Naveed
    Taylor, Roy
    LANCET, 2018, 391 (10120): : 541 - 551
  • [4] A support programme for secondary prevention in patients with transient ischaemic attack and minor stroke (INSPiRE-TMS): an open-label, randomised controlled trial
    Ahmadi, Michael
    Laumeier, Inga
    Ihl, Thomas
    Steinicke, Maureen
    Ferse, Caroline
    Endres, Matthias
    Grau, Armin
    Hastrup, Sidsel
    Poppert, Holger
    Palm, Frederick
    Schoene, Martin
    Seifert, Christian L.
    Kandil, Farid I.
    Weber, Joachim E.
    von Weitzel-Mudersbach, Paul
    Wimmer, Martin L. J.
    Algra, Ale
    Amarenco, Pierre
    Greving, Jacoba P.
    Busse, Otto
    Kohler, Friedrich
    Marx, Peter
    Audebert, Heinrich J.
    LANCET NEUROLOGY, 2020, 19 (01): : 49 - 60
  • [5] Ambulatory management of primary spontaneous pneumothorax: an open-label, randomised controlled trial
    Hallifax, Rob J.
    McKeown, Edward
    Sivakumar, Parthipan
    Fairbairn, Ian
    Peter, Christy
    Leitch, Andrew
    Knight, Matthew
    Stanton, Andrew
    Ijaz, Asim
    Marciniak, Stefan
    Cameron, James
    Bhatta, Amrithraj
    Blyth, Kevin G.
    Reddy, Raja
    Harris, Marie-Clare
    Maddekar, Nadeem
    Walker, Steven
    West, Alex
    Laskawiec-Szkonter, Magda
    Corcoran, John P.
    Gerry, Stephen
    Roberts, Corran
    Harvey, John E.
    Maskell, Nick
    Miller, Robert F.
    Rahman, Najib M.
    LANCET, 2020, 396 (10243): : 39 - 49
  • [6] Randomised Ambulatory Management of Primary Pneumothorax (RAMPP): protocol of an open-label, randomised controlled trial
    Hallifax, Rob
    Laskawiec-Szkonter, Magda
    Dobson, Melissa
    Gerry, Stephen
    Miller, Robert F.
    Harvey, John E.
    Rahman, Najib
    BMJ OPEN RESPIRATORY RESEARCH, 2019, 6 (01)
  • [7] The structured ambulatory post-stroke care program for outpatient aftercare in patients with ischaemic stroke in Germany (SANO): an open-label, cluster-randomised controlled trial
    Schwarzbach, Christopher J.
    Echer, Felizitas Anna
    Ruecker, Viktoria
    Hofmann, Anna-Lena
    Keller, Moritz
    Audebert, Heinrich J.
    von Bandemer, Stephan
    Engelter, Stefan T.
    Geis, Dieter
    Groeschel, Klaus
    Haeusler, Karl Georg
    Hamann, Gerhard F.
    Meisel, Andreas
    Sander, Dirk
    Schutzmeier, Martha
    Veltkamp, Roland
    Heuschmann, Peter Ulrich
    SANO study grp
    LANCET NEUROLOGY, 2023, 22 (09): : 787 - 799
  • [8] Cost-effectiveness of ambulatory care management of primary spontaneous pneumothorax: an open-label, randomised controlled trial
    Luengo-Fernandez, Ramon
    Landeiro, Filipa
    Hallifax, Rob
    Rahman, Najib M.
    THORAX, 2022, 77 (09) : 913 - 918
  • [9] Secondary prevention of stroke. Implementation of a point-of-care, cluster randomised trial using electronic health records (eCRT Study)
    Dregan, A.
    van Staa, T.
    McDermott, L.
    McCann, G.
    Ashworth, M.
    Charlton, J.
    Wolfe, C. D. A.
    Rudd, A.
    Yardley, P.
    Gulliford, M. C.
    CEREBROVASCULAR DISEASES, 2014, 37 : 190 - 190
  • [10] Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial
    Toyoda, Kazunori
    Uchiyatna, Shinichiro
    Yamaguchi, Takenori
    Easton, J. Donald
    Kimura, Kazumi
    Hoshino, Haruhiko
    Sakai, Nobuyuki
    Okada, Yasushi
    Tanaka, Kortaro
    Origasa, Hideki
    Naritomi, Hiroaki
    Houkin, Kiyohiro
    Yamaguchi, Keiji
    Isobe, Masanori
    Minematsu, Kazuo
    LANCET NEUROLOGY, 2019, 18 (06): : 539 - 548